NEW: PepMix Peptide Pools for current SARS-CoV-2 variants

For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

NEW: PepMix Peptide Pools for current SARS-CoV-2 variants

Published on 16/01/2023

The Covid-19 disease has reached an endemic status thus suggesting a need to stay current with vaccination plans and therapy development. More variants have emerged and JPT remains dedicated to provide researchers with up-to-date tools for immune monitoring and immune response profiling covering the SARS-CoV-2 virus’ spike glycoprotein and respective RBD.

Now available PepMix Peptide Pools:

SARS-CoV-2 BA.2.75

SARS-CoV-2 BA.2.75.2

SARS-CoV-2 BF.7

SARS-CoV-2 BQ.1.1

SARS-CoV-2 XBB.1.5

Besides our many other PepMix Peptide Pools or PepStar Peptide Microarrays covering SARS-CoV-2 antigens, we also offer PepMix Pan Select which combine immunodominant epitopes, or PepMix Collections which include many important PepMix’ of important antigens at a lower total cost.

Also, have a look at our dedicated SARS-CoV-2 page with a plethora of information on all the variants and relevant mutations. If you have any questions, or a tailored Custom Peptide Synthesis request please reach out to our experienced customer support team.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Research context

Read sources and limitations before applying a claim.

Epitope Mapping Peptide Sets (EMPS) in Research

PepMix™ Peptide Pools are invaluable for studying immune responses, particularly in vaccine development and infectious disease research. JPT’s EMPS peptide pools are specifically designed to enhance the understanding of T cell reactivity and antigen-specific immune responses. Below, you will find a key study referencing JPT’s PepMix™ Peptide Pools in researches.

Source: jpt.com ↗

JPT's Peptide Pools for Infectious Diseases Research

PepMix™ Peptide Pools are crucial tools for studying immune responses to infectious diseases, including viral and bacterial infections. JPT’s PepMix™ products enable researchers to assess T cell reactivity, improve vaccine formulations, and explore immune protection mechanisms. Below, you will find key studies referencing JPT’s PepMix™ Peptide Pools in various research.

Source: jpt.com ↗

Practical and safety references

These excerpts are educational, not personalised medical instructions.

Potential benefits

Benefits of Custom PepMix™ Peptide Pools

Overlapping peptide pools are preferable to whole proteins for antigen-specific T-cell stimulation because: Simultaneous detection of CD4+ and CD8+ responses in a single sample Equivalent or better stimulation T-cell responses compared to whole protein antigens Antigen spanning peptide pools stimulate T-cells in an HLA independent manner All epitopes covered, epitope spreading addressed Purified peptide pools eliminate risk of toxic inhibition of T-cell responses No false positive T-cell stimulation caused by deletion peptides Superior control compared to phytohemagglutinin (PHA) and concanavalin A (ConA) Improved responses in stored blood and PBM cells compared to whole proteins High-batch-to-batch reproducibility Reliable chemical and biochemical quality control and quality assurance for peptide synthesis and peptide pool generation Prolonged shelf stability when stored freeze dried

Source: jpt.com ↗

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

NEW: PepMix Peptide Pools for current SARS-CoV-2 variants

Epitope Mapping Peptide Sets (EMPS) in Research

JPT's Peptide Pools for Infectious Diseases Research

Benefits of Custom PepMix™ Peptide Pools

Peptide Therapy Guide Editorial Team

Custom SIL peptides - peptide pools

Custom PepMix™ Peptide Pools | JPT

Visit the Whole Wide World of Peptide Pools

This February: RSV Peptide Pools & Arrays 20% OFF